PUBLIC COMPANY
saveSandoz Inc
updated 2mo ago
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugHYRIMOZ26 co-mentions · 13 sources
- drugLarotid14 co-mentions · 7 sources
- drugamoxicillin14 co-mentions · 7 sources
- drugVOQUEZNA DUAL PAK14 co-mentions · 7 sources
- drugAMOXICILLIN AND CLAVULANATE POTASSIUM14 co-mentions · 7 sources
- drugVOQUEZNA TRIPLE PAK14 co-mentions · 7 sources
- drugHUMIRA13 co-mentions · 13 sources
pipeline
33
marketed
23
phase 3
0
catalysts ytd
16
approvals ytd
16
recalls ytd
0
Pipeline(33)
view full pipeline →pipeline depth33 products
23Marketed10Unknown
Marketed
(metformin hydrochloride + sitagliptin phosphate)
Type 2 Diabetes
MarketedHYRIMOZ
MarketedJUBBONTI
MarketedMaxitrol
Anterior Segment Inflammation
MarketedMycamine
Abscess
MarketedNuvigil
Narcolepsy
MarketedPatanase
Seasonal Allergic Rhinitis
MarketedQOLIANA
Ocular Hypertension
MarketedRITALIN LA
MarketedTRAVOPROST
Ocular Hypertension
MarketedTobi Podhaler
Pseudomonas aeruginosa Infections
Marketedampicillin
Bacterial Pneumonia
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that